PHM
vs
VRTX
PHM
VRTX
Over the past 12 months, PHM has underperformed VRTX, delivering a return of -4% compared to the VRTX's +5% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
PHM
VRTX
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Pharma Mar SA
MAD:PHM
|
81.85
EUR
|
|||||
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
465.605
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
PHM, VRTX
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
Pharma Mar SA
Revenue
|
|||||||||||
|
Vertex Pharmaceuticals Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
PHM, VRTX
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
Pharma Mar SA
MAD:PHM
|
|||||||||
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Pharma Mar SA | ||||
|
Vertex Pharmaceuticals Inc | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Pharma Mar SA | ||||
|
Vertex Pharmaceuticals Inc | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
PHM, VRTX
Performance By Year
PHM, VRTX
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.